Scleroderma is a serious disease characterized by excessible accumulation of collagen and other connective tissue components in skin and internal organs. The mechanisms responsible for such accumulation are not known. We will investigate the biochemical characteristics of skin obtained from normals and from patients with scleroderma to determine the nature of the biochemical abnormality. Biosynthesis of collagen in skin organ cultures and tissue cultures from dermal fibroblasts will be examined and the biosynthesized products will be characterized. Differences in the content or structure of the various components present in the tissues or synthesized in the cultures will be identified. Special emphasis will be placed on the identification of the various collagen types present and in the quantitation of their relative proportions. The effects of various cellular and humoral components obtained from patients with scleroderma on the biosynthesis and function of fibroblasts and endothelial cells in culture will be examined to identify factors responsible for the massive connective tissue accumulation. At the present, there is no adequate therapy for scleroderma and the disease progresses relentlessly. We propose a novel approach based on the pharmacological manipulation of the various steps required for synthesis of collagen to attain specific or selective inhibition of connective tissue accumulation. This approach will result in the identification of possible therapeutic agents which may be beneficial in preventing progression of the disease.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Research Project (R01)
Project #
5R01AR019616-12
Application #
3155051
Study Section
General Medicine A Subcommittee 2 (GMA)
Project Start
1987-09-01
Project End
1990-06-30
Budget Start
1988-07-01
Budget End
1989-06-30
Support Year
12
Fiscal Year
1988
Total Cost
Indirect Cost
Name
Thomas Jefferson University
Department
Type
Schools of Medicine
DUNS #
061197161
City
Philadelphia
State
PA
Country
United States
Zip Code
19107
Kumar, S; Singh, J; Rattan, S et al. (2017) Review article: pathogenesis and clinical manifestations of gastrointestinal involvement in systemic sclerosis. Aliment Pharmacol Ther 45:883-898
Wermuth, Peter J; Carney, Kellan R; Mendoza, Fabian A et al. (2017) Endothelial cell-specific activation of transforming growth factor-? signaling in mice induces cutaneous, visceral, and microvascular fibrosis. Lab Invest 97:806-818
Jimenez, Sergio A; Piera-Velazquez, Sonsoles (2016) Endothelial to mesenchymal transition (EndoMT) in the pathogenesis of Systemic Sclerosis-associated pulmonary fibrosis and pulmonary arterial hypertension. Myth or reality? Matrix Biol 51:26-36
Mendoza, Fabian A; Piera-Velazquez, Sonsoles; Farber, John L et al. (2016) Endothelial Cells Expressing Endothelial and Mesenchymal Cell Gene Products in Lung Tissue From Patients With Systemic Sclerosis-Associated Interstitial Lung Disease. Arthritis Rheumatol 68:210-7
Piera-Velazquez, Sonsoles; Mendoza, Fabian A; Jimenez, Sergio A (2016) Endothelial to Mesenchymal Transition (EndoMT) in the Pathogenesis of Human Fibrotic Diseases. J Clin Med 5:
Mendoza, Fabian A; Mansoor, Maryah; Jimenez, Sergio A (2016) Treatment of Rapidly Progressive Systemic Sclerosis: Current and Futures Perspectives. Expert Opin Orphan Drugs 4:31-47
Mendoza, F A; Bai, R; Kebede, A G et al. (2016) Severe eosinophilic fasciitis: comparison of treatment with d-penicillamine plus corticosteroids vs. corticosteroids alone. Scand J Rheumatol 45:129-34
Londin, Eric; Loher, Phillipe; Telonis, Aristeidis G et al. (2015) Analysis of 13 cell types reveals evidence for the expression of numerous novel primate- and tissue-specific microRNAs. Proc Natl Acad Sci U S A 112:E1106-15
Piera-Velazquez, Sonsoles; Jimenez, Sergio A (2015) Role of cellular senescence and NOX4-mediated oxidative stress in systemic sclerosis pathogenesis. Curr Rheumatol Rep 17:473
Piera-Velazquez, Sonsoles; Makul, Alma; Jiménez, Sergio A (2015) Increased expression of NAPDH oxidase 4 in systemic sclerosis dermal fibroblasts: regulation by transforming growth factor ?. Arthritis Rheumatol 67:2749-58

Showing the most recent 10 out of 61 publications